Familial aggregation of high tumor necrosis factor alpha levels in systemic lupus erythematosus

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Mangale, Dorothy ^a   Kariuki, Silvia N ^a   Chrabot, Beverly S ^a   Kumabe, Marissa ^a   Kelly, Jennifer A ^b   Harley, John B ^c,d   James, Judith A ^b   Sivils, Kathy L ^b   Niewold, Timothy B ^e  

^a UNIVERSITY OF CHICAGO   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; FIRST DEGREE RELATIVE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENCE RISK; SPOUSE; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CASE CONTROL STUDY; ENVIRONMENT; FAMILY; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; ENVIRONMENT; FAMILY; FEMALE; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84885646537     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/267430     Document Type: Article

References (41)

1. Harley J. B., Kelly J. A., Kaufman K. M., Unraveling the genetics of systemic lupus erythematosus. Springer Seminars in Immunopathology 2006 28 2 119 130 2-s2.0-33749537076 10.1007/s00281-006-0040-5 (Pubitemid 44526313)
2. Weckerle C. E., Franek B. S., Kelly J. A., Kumabe M., Mikolaitis R. A., Green S. L., Utset T. O., Jolly M., James J. A., Harley J. B., Niewold T. B., Network analysis of associations between serum interferon- α activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis and Rheumatism 2011 63 4 1044 1053 2-s2.0-79953677484 10.1002/art.30187
3. Ko K., Franek B. S., Marion M., Kaufman K. M., Langefeld C. D., Harley J. B., Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus. The Journal of Rheumatology 2012 39 6 1238 1240
4. Niewold T. B., Swedler W. I., Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clinical Rheumatology 2005 24 2 178 181 2-s2.0-17544373868 10.1007/s10067-004-1024-2 (Pubitemid 40552976)
5. Niewold T. B., Interferon alpha-induced lupus: proof of principle. Journal of Clinical Rheumatology 2008 14 3 131 132 2-s2.0-48249136616 10.1097/RHU.0b013e318177627d
6. Kariuki S. N., Niewold T. B., Genetic regulation of serum cytokines in systemic lupus erythematosus. Translational Research 2010 155 3 109 117 2-s2.0-76549136591 10.1016/j.trsl.2009.08.012
7. Niewold T. B., Clark D. N., Salloum R., Poole B. D., Interferon alpha in systemic lupus erythematosus. Journal of Biomedicine and Biotechnology 2010 2010 8 2-s2.0-77955350698 10.1155/2010/948364 948364
8. Salloum R., Niewold T. B., Inteferon regulatory factors in human lupus pathogenesis. Translational Research 2011 157 6 326 331 10.1016/j.trsl.2011.01. 006
9. Weckerle C. E., Niewold T. B., The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clinical Reviews in Allergy and Immunology 2011 40 1 42 49 2-s2.0-79951670346 10.1007/s12016-009-8192-4
10. Niewold T. B., Hua J., Lehman T. J., Harley J. B., Crow M. K., High serum IFN- α activity is a heritable risk factor for systemic lupus erythematosus. Genes and Immunity 2007 8 6 492 502 2-s2.0-34548438559 10.1038/sj.gene.6364408 (Pubitemid 47365615)
11. Niewold T. B., Wu S. C., Smith M., Morgan G. A., Pachman L. M., Familial aggregation of autoimmune disease in juvenile dermatomyositis. Pediatrics 2011 127 5 e1239 e1246 2-s2.0-79955518024 10.1542/peds.2010-3022
12. Kariuki S. N., Moore J. G., Kirou K. A., Crow M. K., Utset T. O., Niewold T. B., Age- and gender-specific modulation of serum osteopontin and interferon- α by osteopontin genotype in systemic lupus erythematosus. Genes and Immunity 2009 10 5 487 494 2-s2.0-67849083066 10.1038/gene.2009.15
13. Kariuki S. N., Crow M. K., Niewold T. B., The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon- α activity and low tumor necrosis factor α levels in patients with lupus. Arthritis and Rheumatism 2008 58 9 2818 2823 2-s2.0-51849117301 10.1002/art.23728
14. Salloum R., Franek B. S., Kariuki S. N., Rhee L., Mikolaitis R. A., Jolly M., Utset T. O., Niewold T. B., Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon- α activity in lupus patients. Arthritis and Rheumatism 2010 62 2 553 561 2-s2.0-75749110600 10.1002/art.27182
15. Niewold T. B., Kelly J. A., Flesch M. H., Espinoza L. R., Harley J. B., Crow M. K., Association of the IRF5 risk haplotype with high serum interferon- α activity in systemic lupus erythematosus patients. Arthritis and Rheumatism 2008 58 8 2481 2487 2-s2.0-49449104525 10.1002/art.23613
16. Kariuki S. N., Kirou K. A., MacDermott E. J., Barillas-Arias L., Crow M. K., Niewold T. B., Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN- α in lupus patients in vivo. Journal of Immunology 2009 182 1 34 38 2-s2.0-59849096879
17. Robinson T., Kariuki S. N., Franek B. S., Kumabe M., Kumar A. A., Badaracco M., Mikolaitis R. A., Guerrero G., Utset T. O., Drevlow B. E., Zaacks L. S., Grober J. S., Cohen L. M., Kirou K. A., Crow M. K., Jolly M., Niewold T. B., Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN- α and serologic autoimmunity in lupus patients. Journal of Immunology 2011 187 3 1298 1303 2-s2.0-80051619284 10.4049/jimmunol.1100857
18. Niewold T. B., Kelly J. A., Kariuki S. N., Franek B. S., Kumar A. A., Kaufman K. M., Thomas K., Walker D., Kamp S., Frost J. M., Wong A. K., Merrill J. T., Alarcón-Riquelme M. E., Tikly M., Ramsey-Goldman R., Reveille J. D., Petri M. A., Edberg J. C., Kimberly R. P., Alarcón G. S., Kamen D. L., Gilkeson G. S., Vyse T. J., James J. A., Gaffney P. M., Moser K. L., Crow M. K., Harley J. B., IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Annals of the Rheumatic Diseases 2012 71 3 463 468 2-s2.0-84857208015 10.1136/annrheumdis-2011-200463
19. Cham C. M., Ko K., Niewold T. B., Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus. Clinical and Developmental Immunology 2012 2012 11 780436 10.1155/2012/780436
20. Kariuki S. N., Franek B. S., Kumar A. A., Arrington J., Mikolaitis R. A., Utset T. O., Jolly M., Crow M. K., Skol A. D., Niewold T. B., Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Research and Therapy 2010 12 4, article R151 2-s2.0-77954877255 10.1186/ar3101
21. Kariuki S. N., Franek B. S., Mikolaitis R. A., Utset T. O., Jolly M., Skol A. D., Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients. Journal of Biomedicine and Biotechnology 2010 2010 7 2-s2.0-77955379528 10.1155/2010/826434 826434
22. Harley I. T. W., Niewold T. B., Stormont R. M., Kaufman K. M., Glenn S. B., Franek B. S., The role of genetic variation near interferon-kappa in systemic lupus erythematosus. 2010 2010 11 706825 10.1155/2010/706825
23. Pothlichet J., Niewold T. B., Vitour D., Solhonne B., Crow M. K., Si-Tahar M., A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. EMBO Molecular Medicine 2011 3 3 142 152 2-s2.0-79952094197 10.1002/emmm.201000120
24. Jensen M. A., Patterson K. C., Kumar A. A., Kumabe M., Franek B. S., Niewold T. B., Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients. Annals of the Rheumatic Diseases 2013 72 4 596 601
25. Weckerle C. E., Mangale D., Franek B. S., Kelly J. A., Kumabe M., James J. A., Large-scale analysis of tumor necrosis factor alpha levels in systemic lupus erythematosus. Arthritis and Rheumatism 2012 64 9 2947 2952
26. Aringer M., Smolen J. S., The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Research and Therapy 2008 10 1, article 202 2-s2.0-47049112010 10.1186/ar2341 (Pubitemid 352044828)
27. Aringer M., Smolen J. S., Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention. Lupus 2004 13 5 344 347 2-s2.0-2942733373 10.1191/0961203303lu1024oa (Pubitemid 38788494)
28. Studnicka-Benke A., Steiner G., Petera P., Smolen J. S., Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. British Journal of Rheumatology 1996 35 11 1067 1074 2-s2.0-0029955420
29. Jacob C. O., McDevitt H. O., Tumour necrosis factor- α in murine autoimmune "lupus" nephritis. Nature 1988 331 6154 356 358 2-s2.0-0023874728 (Pubitemid 18042493)
30. Aringer M., Houssiau F., Gordon C., Graninger W. B., Voll R. E., Rath E., Steiner G., Smolen J. S., Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. Rheumatology 2009 48 11 1451 1454 2-s2.0-73349117550
31. Pan H.-F., Leng R. X., Wang C., Qin W.-Z., Chen L.-L., Zha Z.-Q., Tao J.-H., Ye D.-Q., Association of TNF- α promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis. Rheumatology International 2012 32 7 2083 2092 2-s2.0-79953907752 10.1007/s00296-011-1924-9
32. Mekinian A., Tamouza R., Pavy S., Gestermann N., Ittah M., Mariette X., Miceli-Richard C., Functional study of TNF- α promoter polymorphisms: literature review and meta-analysis. European Cytokine Network 2011 22 2 88 102 2-s2.0-79961009652 10.1684/ecn.2011.0285
33. Hua J., Kirou K., Lee C., Crow M. K., Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis and Rheumatism 2006 54 6 1906 1916 2-s2.0-33745034931 10.1002/art.21890 (Pubitemid 43877940)
34. Niewold T. B., Rivera T. L., Buyon J. P., Crow M. K., Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. Arthritis and Rheumatism 2008 58 2 541 546 2-s2.0-39749158486 10.1002/art.23191 (Pubitemid 351294888)
35. Feng X., Reder N. P., Yanamandala M., Hill A., Franek B. S., Niewold T. B., Reder A. T., Javed A., Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis. Journal of the Neurological Sciences 2012 313 1-2 48 53 2-s2.0-84855604535 10.1016/j.jns.2011.09.032
36. Niewold T. B., Kariuki S. N., Morgan G. A., Shrestha S., Pachman L. M., Gene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in Juvenile dermatomyositis. Journal of Pediatrics 2010 157 4 653 657 2-s2.0-77956392253 10.1016/j.jpeds.2010.04.034
37. Balboni I., Niewold T. B., Morgan G., Limb C., Eloranta M. L., Ronnblom L., Detection of anti-Ro, La, Smith and RNP autoantibodies by autoantigen microarray analysis and interferon-alpha induction in juvenile dermatomyositis. Arthritis and Rheumatism 2013 65 2424 2429 10.1002/art.38038.
38. Risch N., Linkage strategies for genetically complex traits. I. Multilocus models. The American Journal of Human Genetics 1990 46 2 222 228 2-s2.0-0025019555
39. Grondal G., Kristjansdottir H., Gunnlaugsdottir B., Arnason A., Lundberg I., Klareskog L., Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. Arthritis and Rheumatism 1999 42 8 1649 1654 (Pubitemid 30263633)
40. James J. A., Kaufman K. M., Farris A. D., Taylor-Albert E., Lehman T. J. A., Harley J. B., An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. Journal of Clinical Investigation 1997 100 12 3019 3026 2-s2.0-0031465706 (Pubitemid 28022839)
41. Niewold T. B., Interferon alpha as a primary pathogenic factor in human lupus. Journal of Interferon and Cytokine Research 2011 31 12 887 892 2-s2.0-83455169554 10.1089/jir.2011.0071